TREATMENT OF EPILEPSY IN CHILDREN: SPECIAL PHARMACEUTICAL FORMS
Abstract
treatment of epilepsy in children poses a number of difficulties. This is due to the versatility of epileptic syndromes and epilepsy forms in children and to the problem of age limitations to the use of antiepileptic drugs (AED). The use of tableted drugs is often complicated in younger children. AED tablets are sometimes indivisible, or can be divided only in half. In many cases this is not enough to give the child the initial dose of the drug. At the same time, the metabolism of AED in children has its specifics, which permits to administer higher daily doses compared with adult patients. Therefore, it is recommended to administer special pharmaceutical forms of AED, including those that allow prolonged release of the active ingredient. The article presents information concerning modern AED that have special pharmaceutical forms for the treatment of epilepsy in children.
About the Author
Е. D. Belousova
Moscow Scientific-Research Institute of Paediatrics and Paediatric Surgery of the Rosmedtekhnologii
Russian Federation
Department of Psychoneurology and Epileptology
Russian Federation
Department of Psychoneurology and Epileptology
References
1. Jallon P. Epidemiology of childhood epilepsies. In “A practical guide to childhood epilepsies”. Ed. C.P. Panayiotopoulos. Medicinae; Oxford; 2006; P.17-20.
2. Справочник Видаль. Лекарственные препараты в России; 2009; АстраФармСервис; 1740 стр.
3. Депакин Хроносфера. Инструкция по применению препарата. Рег. номер: ЛСР-005197/08 от 03.07.2008.
4. Депакин Cироп. Инструкция по применению препарата. Рег. номер: П N012595/01- 2001 от 19.01.2001.
5. Конвулекс (сироп для детей) инструкция по медицинскому применению препарата. Рег. Номер ПN 011170/01
6. Конвулекс (капли для детей) инструкция по медицинскому применению препарата. Рег. Номер ПN 011170/02 от 29.07.2005
7. Кеппра. Инструкция по медицинскому применению препарата. ЛРС-003170/09- 240409.
8. Трилептал (суспензия для приема внутрь) Рег. Номер: П N 015745/01.
9. Pellock J.M. , Smith, J. M.C. Cloyd C. et al.. Extended-release formulations: simplifying strategies in the management of antiepileptic drug therapy. Epilepsy Behavior; 2004; V.5; P. 301 – 307.
10. Dulac O. and Alvarez J.-C. Bioequivalence of a New Sustained-Release Formulation of Sodium Valproate, Valproate ModifiedRelease Granules, Compared with Existing Sustained-Release Formulations After Onceor Twice-Daily Administration. Pharmacotherapy; 2005; V.25; N1; P.35 – 41.
11. Motte J., Pedespan J.M., Sevestre M. et al. Acceptabilite et tolerance du valproate de sodium, granules a liberation prolongee, en monotherapie chez l’enfant epileptique a partir de trois ans. Archives de pediatrie; 2005; V.12 ; P. 1533-1539.
Review
For citations:
Belousova Е.D. TREATMENT OF EPILEPSY IN CHILDREN: SPECIAL PHARMACEUTICAL FORMS. Epilepsy and paroxysmal conditions. 2009;1(1):26-30. (In Russ.)
Views: 547
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
